EROD assay

MK Mariela Kyoreva
YL Ying Li
MH Mariyah Hoosenally
JH Jonathan Hardman-Smart
KM Kirsten Morrison
IT Isabella Tosi
MT Mauro Tolaini
GB Guillermo Barinaga
BS Brigitta Stockinger
UM Ulrich Mrowietz
FN Frank O. Nestle
CS Catherine H. Smith
JB Jonathan N. Barker
PM Paola Di Meglio
ask Ask a question
Favorite

CYP1A1 enzymatic activity was measured in mouse tail epidermal sheet biopsies and in vitro skewed Th17 cells by the EROD assay, in which the 7-ethoxyresorufin (Sigma-Aldrich) is converted to resorufin (Sigma-Aldrich). Tail mouse skin was processed by the mechanical removal of subcutaneous fat tissue and floated on 0.5% w/v trypsin (Sigma-Aldrich) for 1 hour at 37 °C. Epidermal sheets were mechanically separated, and quadruplicate from each epidermal sheet was transferred to a 96-wells plate. EROD reaction was initiated by adding 2 μM 7-ethoxyresorufin in sodium phosphate buffer (50 mM, PH 8.0) to each well. The plate was incubated at 37 oC for 20 minutes, the reaction was stopped by adding fluorescamine (150 μg/ml in acetonitrile), and epidermal sheets biopsies were discarded. Resorufin formation was measured against a resorufin standard curve on a plate reader (FLUOstar Omega, BMG LabTech, Ortenberg, Germany) with excitation and emission wavelengths of 535 and 590, respectively. CYP1A1 enzymatic activity was normalized for the skin protein content simultaneously determined by fluorescamine fluorescence of a standard curve of BSA (Sigma-Aldrich) at excitation and emission wavelengths of 390 and 480, respectively. In vitro skewed Th17 cells were assayed similarly, and CYP1A1 enzymatic activity was normalized to the IL-17 secreted in each well.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A